AgingResearch.NewsJoin free

Alternate-day fasting + liraglutide

Intervention

1 paper studies it2 findings

Across all fields, 1 paper: none in people yet, 1 in animals

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab
  • Animals1

Outcomes

2

GPR39

upin rats1

1 study

  1. Alternate-day fasting + liraglutide increases GPR39 in rats.

    “Proteomic analysis revealed significant upregulation of G protein-coupled receptor 39 (GPR39) and transmembrane protein 41b (Tmem41b) in the A+L group”

    Animalsin high-fat diet-fed ratsliver5 weeks

    The Proteomic Analysis of Intermittent Fasting Alone or with GLP-1RA in NAFLD Rats

    ADA Scientific Sessions 2025 abstract

More on GPR39

Nonalcoholic fatty liver disease

downin rats1

1 study

  1. Alternate-day fasting + liraglutide decreases nonalcoholic fatty liver disease in rats.

    “The combination of ADF with liraglutide further enhanced these effects, showing greater reductions in body weight, food intake, triglyceride, and LDL levels, along with improved insulin resistance and lower NAFLD scores.”

    Animalsin high-fat diet-fed ratsliver5 weeks

    The Proteomic Analysis of Intermittent Fasting Alone or with GLP-1RA in NAFLD Rats

    ADA Scientific Sessions 2025 abstract

More on Nonalcoholic fatty liver disease

Latest

Related